Foresite Capital Fund VI LP

Holdings History for CASI Pharmaceuticals, Inc. - Ordinary shares, par value US$0.0001 (CASI)

Symbol: CASI
Investment type: Equity / Ordinary shares, par value US$0.0001
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Foresite Capital Fund VI LP ownership in CASI Pharmaceuticals, Inc. Ordinary shares, par value US$0.0001 (CASI)

13 Feb 2026 - Foresite Capital Fund VI LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of CASI Pharmaceuticals, Inc. Ordinary shares, par value US$0.0001 (CASI). This represents 0% ownership of the company. In their previous filing dated 14 Nov 2025, Foresite Capital Fund VI LP had reported owning 979,956 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Foresite Capital Fund VI LP	0%	-105%	$0	0	-979,956	-100%	$1.04	13G/A	31 Dec 2025	13 Feb 2026, 18:03
Foresite Capital Fund VI LP	6.3%	+24%	$1,626,727	979,956	+192,835	+24%	$1.66	13G/A	30 Sep 2025	14 Nov 2025, 16:05
Foresite Capital Fund VI, L.P.	5.1%		$928,803	787,121			$1.18	13G/A	30 Jun 2025	12 Aug 2025, 16:05